Red blood cell transfusion survival in sickle cell disease is reduced by donor characteristics and recipient spleen activity

Abstract: Red blood cell (RBC) transfusion therapy in sickle cell disease (SCD) is used to treat and prevent disease complications by providing nonsickle erythrocytes that survive for weeks in circulation. The suppression of sickle hemoglobin between transfusion episodes is dependent on donor RBC su...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Marianne E. M. Yee, Patricia E. Zerra, Richard O. Francis, Kirk A. Easley, Christopher M. Lough, James W. McCoy, Zahra Naseh, Bhaveshkumar B. Delvadia, Ashishkumar K. Parikh, Hailly E. Butler, Sean R. Stowell, Clinton H. Joiner, Cassandra D. Josephson, John D. Roback, Ross M. Fasano
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2026-07-01
Цуврал:	Blood Advances
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2473952926003198
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!